Gene Review:
JPH3 - junctophilin 3
Homo sapiens
Synonyms:
CAGL237, HDL2, JP-3, JP3, Junctophilin type 3, ...
- The effect of cessation and resumption of moderate alcohol intake on serum high-density-lipoprotein subfractions. A controlled study. Haskell, W.L., Camargo, C., Williams, P.T., Vranizan, K.M., Krauss, R.M., Lindgren, F.T., Wood, P.D. N. Engl. J. Med. (1984)
- Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. Eckel, R.H. N. Engl. J. Med. (1989)
- Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. Gaziano, J.M., Buring, J.E., Breslow, J.L., Goldhaber, S.Z., Rosner, B., VanDenburgh, M., Willett, W., Hennekens, C.H. N. Engl. J. Med. (1993)
- Physiologic testosterone levels in normal men suppress high-density lipoprotein cholesterol levels. Bagatell, C.J., Knopp, R.H., Vale, W.W., Rivier, J.E., Bremner, W.J. Ann. Intern. Med. (1992)
- Associations of the HDL2 and HDL3 cholesterol subfractions with the development of ischemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies. Sweetnam, P.M., Bolton, C.H., Yarnell, J.W., Bainton, D., Baker, I.A., Elwood, P.C., Miller, N.E. Circulation (1994)
- Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes. Stevanin, G., Fujigasaki, H., Lebre, A.S., Camuzat, A., Jeannequin, C., Dode, C., Takahashi, J., San, C., Bellance, R., Brice, A., Durr, A. Brain (2003)
- Lifestyle determinants of HDL2- and HDL3-cholesterol levels in a hypercholesterolemic male population. Mänttäri, M., Koskinen, P., Manninen, V., Tenkanen, L., Huttunen, J.K. Atherosclerosis (1991)
- Serum lipids and lipoproteins in postmenopausal women receiving transdermal oestrogen in combination with a levonorgestrel-releasing intrauterine device. Raudaskoski, T.H., Tomás, E.I., Paakkari, I.A., Kauppila, A.J., Laatikainen, T.J. Maturitas. (1995)
- A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2. Holmes, S.E., O'Hearn, E., Rosenblatt, A., Callahan, C., Hwang, H.S., Ingersoll-Ashworth, R.G., Fleisher, A., Stevanin, G., Brice, A., Potter, N.T., Ross, C.A., Margolis, R.L. Nat. Genet. (2001)
- Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. Brown, B.G., Zhao, X.Q., Chait, A., Fisher, L.D., Cheung, M.C., Morse, J.S., Dowdy, A.A., Marino, E.K., Bolson, E.L., Alaupovic, P., Frohlich, J., Albers, J.J. N. Engl. J. Med. (2001)
- A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. Stampfer, M.J., Sacks, F.M., Salvini, S., Willett, W.C., Hennekens, C.H. N. Engl. J. Med. (1991)
- The ratio of waist-to-hip circumference, plasma insulin level, and glucose intolerance as independent predictors of the HDL2 cholesterol level in older adults. Ostlund, R.E., Staten, M., Kohrt, W.M., Schultz, J., Malley, M. N. Engl. J. Med. (1990)
- High plasma vitamin C associated with high plasma HDL- and HDL2 cholesterol. Hallfrisch, J., Singh, V.N., Muller, D.C., Baldwin, H., Bannon, M.E., Andres, R. Am. J. Clin. Nutr. (1994)
- The association between dyslipidaemia and obesity in Chinese men after adjustment for insulin resistance. Ko, G.T., Chan, J.C., Cockram, C.S. Atherosclerosis (1998)
- Behavioral correlates of plasma sex hormones and their relationships with plasma lipids and lipoproteins in Japanese men. Handa, K., Ishii, H., Kono, S., Shinchi, K., Imanishi, K., Mihara, H., Tanaka, K. Atherosclerosis (1997)
- Probucol treatment in hypercholesterolemic patients: effects on lipoprotein composition, HDL particle size, and cholesteryl ester transfer. Bagdade, J.D., Kaufman, D., Ritter, M.C., Subbaiah, P.V. Atherosclerosis (1990)
- HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway. Matsuura, F., Wang, N., Chen, W., Jiang, X.C., Tall, A.R. J. Clin. Invest. (2006)
- Regulation of high density lipoprotein receptor activity in cultured human skin fibroblasts and human arterial smooth muscle cells. Oram, J.F., Brinton, E.A., Bierman, E.L. J. Clin. Invest. (1983)
- Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency. Ikewaki, K., Rader, D.J., Sakamoto, T., Nishiwaki, M., Wakimoto, N., Schaefer, J.R., Ishikawa, T., Fairwell, T., Zech, L.A., Nakamura, H. J. Clin. Invest. (1993)
- HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men. Salonen, J.T., Salonen, R., Seppänen, K., Rauramaa, R., Tuomilehto, J. Circulation (1991)
- Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Fan, J., Wang, J., Bensadoun, A., Lauer, S.J., Dang, Q., Mahley, R.W., Taylor, J.M. Proc. Natl. Acad. Sci. U.S.A. (1994)
- Specific high-affinity binding of high density lipoproteins to cultured human skin fibroblasts and arterial smooth muscle cells. Biesbroeck, R., Oram, J.F., Albers, J.J., Bierman, E.L. J. Clin. Invest. (1983)
- Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. Navab, M., Imes, S.S., Hama, S.Y., Hough, G.P., Ross, L.A., Bork, R.W., Valente, A.J., Berliner, J.A., Drinkwater, D.C., Laks, H. J. Clin. Invest. (1991)
- Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men. Krauss, R.M., Lindgren, F.T., Williams, P.T., Kelsey, S.F., Brensike, J., Vranizan, K., Detre, K.M., Levy, R.I. Lancet (1987)
- Genetic control of low-density-lipoprotein subclasses. Austin, M.A., Krauss, R.M. Lancet (1986)
- The molar ratio of the two major polypeptide components of human high density lipoprotein. Friedberg, S.J., Reynolds, J.A. J. Biol. Chem. (1976)
- Insulin and sulfonylurea therapy in NIDDM patients. Are the effects on lipoprotein metabolism different even with similar blood glucose control? Romano, G., Patti, L., Innelli, F., Di Marino, L., Annuzzi, G., Iavicoli, M., Coronel, G.A., Riccardi, G., Rivellese, A.A. Diabetes (1997)
- Exclusion of mutations in the PRNP, JPH3, TBP, ATN1, CREBBP, POU3F2 and FTL genes as a cause of disease in Portuguese patients with a Huntington-like phenotype. Costa, M.d.o. .C., Teixeira-Castro, A., Constante, M., Magalhães, M., Magalhães, P., Cerqueira, J., Vale, J., Passão, V., Barbosa, C., Robalo, C., Coutinho, P., Barros, J., Santos, M.M., Sequeiros, J., Maciel, P. J. Hum. Genet. (2006)
- Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: possible contribution of phospholipase A2 to this atherogenic profile. Hurt-Camejo, E., Paredes, S., Masana, L., Camejo, G., Sartipy, P., Rosengren, B., Pedreno, J., Vallve, J.C., Benito, P., Wiklund, O. Arthritis Rheum. (2001)
- Changes in lipoprotein composition in women receiving two low-dose oral contraceptives containing ethinylestradiol and gonane progestins. Harvengt, C., Desager, J.P., Gaspard, U., Lepot, M. Contraception. (1988)
- Racial differences in plasma high-density lipoproteins in patients receiving hemodialysis. A possible mechanism for accelerated atherosclerosis in white men. Goldberg, A.P., Harter, H.R., Patsch, W., Schechtman, K.B., Province, M., Weerts, C., Kuisk, I., McCrate, M.M., Schonfeld, G. N. Engl. J. Med. (1983)
- Predictors of the presence and extent of peripheral arterial occlusive disease. Drexel, H., Steurer, J., Muntwyler, J., Meienberg, S., Schmid, H.R., Schneider, E., Gröchenig, E., Amann, F.W. Circulation (1996)
- Endotoxin-induced mortality in bile duct-ligated rats after administration of reconstituted high-density lipoprotein. Sewnath, M.E., Levels, H.H., Oude Elferink, R., van Noorden, C.J., ten Kate, F.J., van Deventer, S.J., Gouma, D.J. Hepatology (2000)
- A 70-kDa apolipoprotein designated ApoJ is a marker for subclasses of human plasma high density lipoproteins. de Silva, H.V., Stuart, W.D., Duvic, C.R., Wetterau, J.R., Ray, M.J., Ferguson, D.G., Albers, H.W., Smith, W.R., Harmony, J.A. J. Biol. Chem. (1990)